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Abstract: This study aims to investigate the cardiac electrical remodeling associated with intoxication
by methylmercury (MeHg). We evaluated the chronic effects of MeHg on in vivo electrocardiograms
and on ex vivo action potentials and depolarizing (ICa-L) and repolarizing (Ito) currents. The acute effect
of MeHg was evaluated on HEK293 cells expressing human ERG, Kv4.3 and KCNQ1/KCNE1 channels.
Chronic MeHg treatment increased QTc and Tpeak–Tend interval duration, prolonged action potential
duration and decreased amplitude of Ito and ICa-L. In addition, heterologously expressed IhKv4.3, IhERG
or IhKCNQ1/KCNE1 decreased after acute exposure to MeHg at subnanomolar range. The introduction
of the in vitro effects of MeHg in a computer model of human ventricular action potentials triggered
early afterdepolarizations and arrhythmia. In conclusion, cardiac electrical remodeling induced by
MeHg poisoning is related to the reduction of Ito and ICa-L. The acute effect of MeHg on hKv4.3;
hERG and hKCNQ1/KCNE1 currents and their transposition to in silico models show an association
between MeHg intoxication and acquired Long QT Syndrome in humans. MeHg can exert its high
toxicity either after chronic or acute exposure to concentrations as low as picomolar.
Keywords: mercury; cardiac; electrical remodeling; ion current; arrhythmia
1. Introduction
Some metals found in nature are essential for life, whereas others have no biologic significance
beyond their toxic potential. Heavy metals such as mercury (Hg), cadmium (Cd), arsenic (As) and
lead (Pb) are the main chemical contaminants in the environment and can cause organic dysfunctions
such as neurological, renal, immunological or teratogenic disorders [1–3].
Mercury can cause deleterious effects on human health, which depend on the chemical form,
amount, route of exposure and differences in vulnerability among exposed subjects [4–7]. The main
target organs for Hg toxicity are brain [8], myocardium [9], liver and kidney [10], skin [11], lung [12],
testis and prostate [13], which are associated with dysfunction after either acute or chronic exposure.
The organic form of mercury, the methylmercury (MeHg), is the most toxic chemical form of
Hg and it is widely distributed in the environment, which can affect human health mainly through
consumption of contaminated food [14,15]. At the cardiac level, MeHg contamination associates with
changes in heart rate variability [16], which is described as a situation that generates risk of cardiac
arrhythmias and sudden death [17–21]. In addition, abnormalities in the ST segment and in the T
wave of the electrocardiogram (ECG) followed by death from cardiac arrest caused by organic Hg
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poisoning were described decades ago [22]. However, as far as we know, further studies on the ECG of
Hg exposed people have not been subsequently made.
Even though several evidences strongly suggest the potential cardiac toxicity of MeHg, the basis
and the mechanism underlying are poorly understood yet. Therefore, the aim of this study was
to investigate whether acute or chronic methylmercury poisoning may promote cardiac electrical
remodeling with arrhythmogenic potential. We evaluated electrocardiographic parameters in vivo,
action potentials in cardiac preparations ex vivo and ionic currents in rat cardiomyocytes and HEK293
cells in vitro. Finally, transposition of the results to in silico models shows an association between
MeHg intoxication and prolonged action potential and arrhythmias in humans. Taken together the
results obtained here support the hypothesis that MeHg impairs the cardiac electrical functions and
increase the arrhythmic probability.
2. Results
2.1. MeHg Treatment Induced Weight Loss and Higher Mortality
After 4 weeks of treatment, no significant changes were observed in the control group, whereas
the MeHg-treated group showed substantial weight loss (312 ± 6 vs. 261.4 ± 13.3 g in control vs. MeHg,
respectively, p < 0.01) and mortality (0/21 vs. 11/30 death animals in control vs. MeHg, respectively,
p < 0.05).
Although the absolute weight of heart and liver was reduced after 4 weeks of MeHg treatment,
the relative weight was changed in neither heart, liver nor lungs when normalized to the total body
weight or tibia length.
Taken together these results depict that MeHg treatment increases mortality and impairs the
energetic metabolism since drastically decreased the normal weight gain of the treated rats.
2.2. QTc and APD90 Were Longer in the MeHg-Treated Group
Electrocardiographic recordings were performed before and after 4 weeks of treatment with
MeHg (Figure 1). Compared to control, MeHg-treated rats had prolonged QT interval after 4 weeks
treatment. The ECGs of MeHg-treated rats also showed a prolongation of the RR interval compared to
control animals. In order to overcome the effects of the frequency on QT interval (the time between the
beginning of the QRS complex and the endo of the T wave) duration it was corrected to the heart rate.
Thus, the corrected QT interval (QTc) values were also higher in MeHg-treated animals when compared
to the age-matched control group. The Tpeak–Tend interval is another electrocardiographic risk marker
of arrhythmic and mortality outcomes and it was also significantly prolonged in MeHg-treated animals
(Figure 1).
The ECG changes seen in MeHg-treated animals represent a substrate for the development of
cardiac arrhythmias, so the cellular mechanisms of these alterations must be explored. In order
to identify the mechanisms responsible for the alterations found in the electrocardiogram of
MeHg-treated animals, the action potentials of ventricular muscle strips were recorded (Figure 2 and
Supplementary Table S1).
MeHg treatment had no effect either on resting membrane potential, on AP amplitude or on
maximum upstroke velocity (dV/dt). However, also as observed in the ECG, MeHg prolonged the
ventricular repolarization at the cellular level significantly increasing the APD90. This prolongation
was evident at any Basic Cycle Length (BCL) tested (Figure 2B). The AP triangulation, other important
parameter accepted as a pro-arrhythmogenic marker, was also prolonged in a statistically significant
manner at higher BCLs of stimulation (Figure 2C).
Collectively, these data support the idea that MeHg induces strong electrical changes consistently
associated with cardiac pro-arrhythmogenic events: lengthened the QTc, increased the Tpeak–Tend and
prolonged the APD90.
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Figure 1. Chronic MeHg treatment prolongs cardiac repolarization in vivo. (A) Electrocardiograms of 
a conscious animal before and 4 weeks after treatment with MeHg 3 mg/kg·day (dashed lines show 
the QT interval). RR interval (B), QT interval, (C) heart rate corrected QT interval, QTc, (D) and 
repolarization dispersion, Tpeak–Tend (E) were prolonged after MeHg treatment. n = 13 control and 15 
MeHg-treated animals. * p < 0.05; ** p < 0.01. 
The ECG changes seen in MeHg-treated animals represent a substrate for the development of 
cardiac arrhythmias, so the cellular mechanisms of these alterations must be explored. In order to 
identify the mechanisms responsible for the alterations found in the electrocardiogram of MeHg-
treated animals, the action potentials of ventricular muscle strips were recorded (Figure 2 and 
Supplementary Table S1). 
 
Figure 2. MeHg prolongs ventricular action potential duration. (A) ventricular action potentials were 
recorded in epicardial strips from control and MeHg-treated animals; (B) action potential duration at 
90% of repolarization (APD90) and (C) action potential (AP) triangulation at different basic cycle 
length (BCL), in control (open symbols) or after 4 weeks of treatment with MeHg (filled symbols). * p 
< 0.05. n = 7 control and 14 MeHg-treated hearts per group. 
MeHg treatment had no effect either on resting membrane potential, on AP amplitude or on 
maximum upstroke velocity (dV/dt). However, also as observed in the ECG, MeHg prolonged the 
ventricular repolarization at the cellular level significantly increasing the APD90. This prolongation 
was evident at any Basic Cycle Length (BCL) tested (Figure 2B). The AP triangulation, other 
important parameter accepted as a pro-arrhythmogenic marker, was also prolonged in a statistically 
significant manner at higher BCLs of stimulation (Figure 2C). 
Figure 1. Chronic MeHg treatment prolongs cardiac repolarization in vivo. (A) Electrocardiograms of
a conscious animal before and 4 weeks after treatment with MeHg 3 mg/kg·day (dashed lines show
the QT interval). RR interval (B), QT interval, (C) heart rate corrected QT interval, QTc, (D) and
repolarization dispersion, Tpeak–Tend (E) were prolonged after MeHg treatment. n = 13 control and 15
MeHg-treated animals. * p < 0.05; ** p < 0.01.
3 of 12 
 
 
Figure 1. Chronic MeHg treatment prolongs cardiac repolarization in vivo. (A) Electrocardiograms of 
a conscious animal before and 4 weeks after treatment with MeHg 3 mg/kg·day (dashed lines show 
the QT interval). RR interval (B), QT interval, (C) heart rate corrected QT interval, QTc, (D) and 
repolarization dispersion, Tpeak–Tend (E) were prolonged after MeHg treatment. n = 13 control and 15 
MeHg-treated animals. * p < 0.05; ** p < 0.01. 
The ECG changes seen in MeHg-treated animals represent a substrate for the development of 
cardiac arrhythmias, so the cellular mechanisms of these alterations must be explored. In order to 
identify the mechanisms responsible for the alterations found in the electrocardiogram of MeHg-
treated animals, the action potentials of ventricular muscle strips were recorded (Figure 2 and 
Supplementary Table S1). 
 
Figure 2. MeHg prolongs ventricular action potential duration. (A) ventricular action potentials were 
recorded in epicardial strips from control and MeHg-treated animals; (B) action potential duration at 
90% of repolarization (APD90) and (C) action potential (AP) triangulation at different basic cycle 
length (BCL), in control (open symbols) or after 4 weeks of treatment with MeHg (filled symbols). * p 
< 0.05. n = 7 control and 14 MeHg-treated hearts per group. 
MeHg treatment had no effect either on resting membrane potential, on AP amplitude or on 
maximum upstroke velocity (dV/dt). However, also as observed in the ECG, MeHg prolonged the 
ventricular repolarization at the cellular level significantly increasing the APD90. This prolongation 
was evident at any Basic Cycle Length (BCL) tested (Figure 2B). The AP triangulation, other 
important parameter accepted as a pro-arrhythmogenic marker, was also prolonged in a statistically 
significant manner a igher BCLs of stimulation (Fi ur  2C). 
l
icar ial strips from control and MeHg-treated animals; (B) action potential duration
at 90% of repolarization (APD90) and (C) action potential (AP) triangulation at differe t
( ), in control (open symbols) or after 4 weeks of treatment with MeHg (filled symbols).
* p < 0.05. n = 7 c ntrol and 14 MeHg- reated hearts per group.
2.3. MeHg Prolongs the Cardiac Ventricular Repolarization by Decreasing Ito Current
The AP shape nd duration is determined by a fine alance betw en the outward repolarizing
currents (i.e., tra sient outward pot ssium curr nt—Ito) and the inward depolarizing currents
(i.e., L-type Ca2+ current, ICa-L). Thus, the diff ences in AP duration can be due to changes in
either outw rd or inward currents. Chronic treatme t with MeHg induced a ~44% reduction of the
ICa-L d nsity i comparison with control non treated animals (Figure 3A). H wever, no changes were
found in the biophysical properties measur d here, as observed by the similar values obtained in both
activation and inactivation half voltages (Vh) in both groups studied (Supplementary Table S2).
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relationship obtained in myocytes from animals treated with vehicle (open symbols, n = 7) or with 
MeHg (filled symbols, n = 6). (B) Ito traces recorded at potentials between -50 and +60 mV in ventricular 
myocytes isolated from animals after 4 weeks in control conditions or treated with MeHg. Current–
voltage relationship obtained in myocytes from animals treated with vehicle (open symbols, n = 18) 
or with MeHg (filled symbols, n = 14). ** p < 0.01. 
While ICa-L is the main depolarizing current that determines the action potential duration in rats, 
Ito is the pivotal repolarizing current that regulates the action potential duration in rats. Four weeks 
of treatment with MeHg reduced the amplitude of Ito in a statistically significant manner in 
comparison with control animals at all voltages over +10 mV (Figure 3B). When we explored the 
biophysical properties of the Ito, it was observed that MeHg shifted both the activation and 
inactivation half voltages to more negative potentials. Finally, recovery from Ito inactivation was 
slowed by MeHg treatment, as can be seen in the larger recovery time constant (Supplementary Table 
S2). 
2.4. Methylmercury Decrease the Key Human Repolarizing Cardiac Currents 
All results demonstrated that MeHg induced cardiac electrical remodeling and the main 
molecular mechanisms in vivo in rats. Next, a set of experiments were performed in order to assess 
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Figure 3. MeHg treatment reduces the transient outward K+ and the L-type Ca2+ currents in ventricular
myocytes. (A) ICa-L currents were recorded at voltages from −50 to +60 mV in ventricular myocytes
isolated from animals after 4 weeks in control conditions or treated with MeHg. Current–voltage
relationship obtained in myocytes from animals treated with vehicle (open symbols, n = 7) or with
MeHg (filled symbols, n = 6). (B) Ito traces recorded at potentials between −50 and +60 mV in
ventricular myocytes isolated from animals after 4 weeks in control conditions or treated with MeHg.
Current–voltage relationship obtained in myocytes from animals treated with vehicle (open symbols,
n = 18) or with MeHg (filled symbols, n = 14). ** p < 0.01.
While ICa-L is the main depolarizing current that determines the action potential duration in rats,
Ito is the pivotal repolarizi g current that regula es the action potential duration i r ts. Four weeks of
treatment with M Hg reduced the amplitude of Ito in a sta stically significan man er in comparison
with control animals at all voltages ov r +10 mV (Figure 3B). When we explored the biophysical
properties of the Ito, it was observed that MeHg shifted both the activation and inactivation half
voltage to more negative poten ials. Finally, recovery from Ito inactivation was slowed by MeHg
treatment, as c n be seen in the la ger reco ry time consta t (Supplem ntary Table S2).
2.4. Methylmercury Decrease the Key Human Repolarizing Cardiac Currents
All results demonstrated that MeHg induced cardiac electrical remodeling and the main molecular
mechanisms in vivo in rats. Next, a set of experiments were performed in order to assess whether
MeHg could change the density and/or the characteristics of th main repolarizi currents in the
human heart: the Ito, carried by Kv4.3 channels; IKr, carried by hERG or Kv11.1 channels; and IKs,
carried by the combinatio of Kv7.1 channels and the accesso y protein MinK.
HEK293 cells expressing the human cardiac K+ channels alpha subunit Kv4.3 were challenged to
MeHg at different concentrations. As observed in Figure 4A MeHg was able to reduce in a concentration
dependent manner (from 0.01 to 1 nM) the IKv4.3 density. On the other hand, neither the inactivation
half voltage nor the recovery from inactivation time constant were changed by the acute exposure to
MeHg (Supplementary Table S3).
The main repolarizing current in the human ventricle is IKr, carried by the Kv11.1 or hERG
channel protein. Thus, the IhERG in HEK293 cells stably expressing hERG channels was recorded in the
presence of different MeHg concentrations. Acute exposure to MeHg reduced IhERG current amplitude
in a concentration dependent manner (Figure 4B). The current was reduced by a concentration as low
as 0.01 nM and almost disappeared at concentration of 1 nM. Neither the activation half voltage nor
the reversal potential of IhERG were changed by any concentration of MeHg (Supplementary Table S3).
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i r . r c s r l ri ti c ilit i c lls i itr . r s t ti tr c s
a era e current density-voltage relationships obtained in HEK293 cells expressing (A) Kv4.3 channels,
(B) hERG channels, or (C) Kv7.1/KCNE1 channels. MeHg acute exposure reduces all currents in a
concentration dependent manner. n = 8–15 cells. * p < 0.05; ** p < 0.01.
Finally, HEK293 cells were transfected with both the Kv7.1 channel alpha subunit and the accessory
protein KCNE1 or MinK, which assemble to form the IKs conducting channel. The IKs was recorded
and exposed to increasing concentrations of MeHg. IKs was reduced in a concentration dependent
manner (Figure 4C). In addition, the current properties were modulated by MeHg perfusion at
different concentrations. Thus, MeHg shifted the activation half voltage to more positive potentials
(Supplementary Table S3).
2.5. MeHg Is Pro-Arrhythmic in Human Ventricle In Silico
The data obtained in human ion currents clearly suggest that MeHg is able to negatively modulate
the key ve tricular repolarizing potassium curre ts. Thus, the potential arrhythmogeni effect of
MeHg was tested in silico.
Ventricular AP models of 100 different healthy umans with different ion ch nnel densities wer
generated either in resting conditions or after β-adrenergic stimulation. Then, the results on the
percentage of the current reduction obtained in human HEK293 cells transfected with K+ channels
present in the human ventricle were i troduced i the models in order to establish a similar simulated
condition. When ionic conductance of each channel was changed to simulate an exposure to 0.01 nM
MeHg, it can be seen a prolongation of APD, but no arrhythmia was observed. It is widely accepted
that when a reduction of key potassium ion channels prolongs APD, a β-adrenergic stimulation could
act as a trigger of ventricular arrhythmias. In the present work, adding a β-adrenergic stimulation after
MeHg exposure early after depolarization (EADs) and arrhythmias appeared in 30% of the models
(Figure 5). As can be also seen in Figure 5, MeHg at a concentration of 0.1 nM induced EADs and
arrhythmia in almost all simulated individuals in resting conditions.
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compared with people with different works in the same countries. The higher mortality in people 
chronically exposed to Hg was associated with cardiovascular diseases such as hypertension, cardiac 
ischemia or cardiac stroke [23,24]). In addition to the chronic effects, acute Hg exposure has been 
directly related to sudden death, in some cases from unknown origin and others from cardiac arrest 
[22,25]. 
In the present work, chronic MeHg exposure reduced the cardiac rhythm, prolonged the rate 
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Figure 5. Modeling the effects of acute MeHg-induced changes in ion currents on human ventricular
action potential. Computational models were generated to simulate action potential of 100 control
individuals in resting conditions and under β-adrenergic stimulation. For clarity, only the first 15 traces
are shown. When the ionic conductances were changed to simulate the effects of 0.01 nM MeHg AP
duration increases in resting conditions, but after β-adrenergic stimulation, 33% of action potentials
generated early afterdepolarizations and arrhythmia. When the ionic conductances were changed
to simulate the effects of 0.1 nM MeHg 98% models showed early afterdepolarizations (EADs) and
arrhythmia in resting conditions and 100% after β-adrenergic stimulation.
3. Discussion
Thousands of workers from mercury mines and mills were studied along the 20th century in
Europe [23]. The study concluded that the mortality was higher among these workers when compared
with people with different works in the sam countries. The higher mortality in people chronically
exposed to Hg was associate with cardi vascular diseases s ch as hyp rtension, ca diac ischemia or
ca dia stroke [23,24]. In addition to th chronic effects, a te Hg expo ure as been directly rel ted to
udden death, in some cases from unknown rigin and others from cardiac arrest [22,25].
In the present work, chronic MeHg exposure reduced the cardi c rhythm, prolonged the ate
corrected ventricular repolarization time (QTc) and increased ventricular repolarization dispersion
(Tpeak–Tend), parameters ass ciated with increas d risk of cardi c arrhythmia. Despite of high
mortality obse ved in hum n popula ons exposed to Hg, we found no studi s regarding the effects of
this heavy metal on hum n cardiac electrophysiology. There are, however, electrocardiographic studies
with arsenic, another heavy metal, in leukemic patients treated with As2O3 and in eneral population
chronically exposed to arsenic ontaminated water [26,27]. Int restingly, th se works report similar
electrocardiog aphic bnormalities than those we observe in ra chronically exposed to MeHg.
Since the ele trocardi gram is th result of the summation of the action potentials of every
cardiac cell, we explored the effects of in vivo chronic MeHg exposure on the AP characteristics on
ventricular strips from treated and untreated rats. As expected, in cardiac strips from hearts isolated
from animals with prolonged QTc, the ventricular repolarization was also prolonged at the cellular level.
The APD90 and the AP triangulation were longer when compared to control animals. The increase
in cardiac AP duration could be due to an increase of the depolarizing Ca2+ current ICa-L, a decrease
of the repolarizing K+ currents or both. In the present work, both ICa-L, and Ito were reduced after
chronic in vivo exposure to MeHg. This reduction in the two currents at the same time can explain the
absence of effect on APD30, since this parameter reflects the duration of the plateau phase of the AP.
During this phase, these two currents balance one to each other and the reduction in both of them at
the same time maintains the equilibrium. Since ICa-L is predominant in the initial phase of the plateau,
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a decrease in the plateau duration could be expected. However, the great reduction in Ito is not able to
rapidly repolarize the cell even in the condition of reduced ICa-L. Overall, as reflected in the APD30,
at the initial phase of the plateau there is neither a prolongation nor a shortening. At the end of the
plateau, ICa-L is inactivated, and Ito is the predominating current, resulting in a prolongation of the
APD90. There are no studies in the literature about the effects of in vivo MeHg exposure on cardiac
Ca2+ or K+ currents, but similar reductions were observed in calcium and potassium currents of rat
dorsal root ganglion neurons [28,29].
Next, we wanted to explore whether the effect observed in rat Ito could also be reflected on the
main Ito alpha subunit in human, Kv4.3. Acute in vitro exposure to MeHg of cells expressing the
hKv4.3 channels induced a concentration dependent reduction of the IhKv4.3 with no effect on the
biophysical properties of the current. In contrast, chronic in vivo treatment with MeHg reduced the Ito
current, but also shifted both activation and inactivation half voltages and slowed the current recovery
from inactivation. These differences between in vivo and in vitro effects could be due to an effect of
MeHg on the channel regulation. One limitation of the study is that in cardiac myocytes Ito carries
through Kv4.3 channels associated with auxiliary subunits such as KChIP2, whereas in HEK293 cells
the current was carried out only through Kv4.3 channels. MeHg in vivo could affect the association of
the channel with accessory proteins or their intracellular signaling pathway regulation. Thus, MeHg
decreases Ito current and thus prolongs repolarization providing a cellular substrate for arrhythmia.
Additionally, the results obtained in the human Kv4.3 alpha subunit strongly suggest that MeHg exerts
a direct modulation of the channel.
The main repolarizing current in the human ventricle is the rapid delayed rectifier potassium
current IKr. This current is carried through the Kv11.1 or hERG channel. The data showed a
concentration dependent reduction of the IhERG in the subnanomolar range. This result is similar to
that found after exposure of these channels to other heavy metals such as cobalt or arsenic [30,31].
The slow delayed rectifier K+ current, IKs, is responsible for the adaptation of the AP duration to
different heart rates and adrenergic stimulation. This current is carried through a channel formed by
the Kv7.1 alpha subunit with the regulatory protein KCNE1. In vitro exposure induced a concentration
dependent reduction of IKs and a positive shift in the voltage dependence of activation. These results
also are in agreement with those obtained after Kv7.1/KCNE1 exposure to arsenic [31].
Finally, in order to translate the experimental data obtained on human K+ channels regarding the
susceptibility to trigger arrhythmia to human hearts, we used computer simulations of human cardiac
action potentials. When the effect of 0.01 nM MeHg on each current was introduced in the models,
the action potential duration increased in resting conditions, in accordance with the prolongation of
the QT interval and APD90 observed in treated rats and consistent with the reduction of the amplitude
of the repolarizing K+ currents. It is important to note that in the AP models, EADs and arrhythmias
emerged only under β-adrenergic stimulation, also consistent with the reduction observed in IKs.
In conclusion, MeHg induces ventricular electrical remodeling prone to cardiac arrhythmias.
MeHg can exert its high toxicity either after chronic or acute exposure to concentrations as low as the
picomolar range.
4. Materials and Methods
4.1. Animals and Experimental Protocol
All animal experiments comply with the National Institutes of Health guide for the care and
use of Laboratory animals (NIH Publications No. 8023, revised 1978). All experimental procedures
were approved by the Committee for Ethics in Animal Experimentation of the Federal University
of Rio de Janeiro (protocol N◦ IBCCF-109 and 029/14). Male Wistar rats (200–250 g) were used in
this study. The animals were kept in boxes maintained at an approximate temperature of 23 ◦C,
12 h light/dark cycle and access to food and water ad libitum. The animals were randomly distributed
in two experimental groups, named MeHg and Ctrl group, respectively, which received daily treatment,
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for 28 days by gavage, with a solution containing 3 mg/kg·day of methylmercury chloride (CH3HgCl)
or equivalent volume of vehicle (MilliQ water). The dose and duration of treatment was selected
because it is in the medium range of dosage described to induce symptoms of MeHg intoxication such
as decreased mobility and ataxia [32–34].
At the end of experimental period, the animals were subjected to biometric and electrocardiographic
evaluation in vivo. Then, the animals were heparinized (500 IU/kg of sodium heparin, Sigma-Aldrich,
Sant Louis, MO, USA) intraperitoneal and euthanized by cervical dislocation under anesthesia
with isoflurane.
4.2. Biometric Analysis
After euthanasia, the lungs, liver and heart were removed and weighed using the same balance in
which the body weight was measured (Marte A500, São Paulo, SP, Brazil). The ratios between heart,
liver and lung weights with either body weight or tibia length were calculated to establish the indirect
rates of cardiac hypertrophy, venous congestion and pulmonary congestion, respectively.
4.3. In Vivo Electrocardiogram
Electrocardiogram recording was carried out in conscious animals by a non-invasive method.
Electrodes were positioned in DII derivation and connected by flexible cables to a differential AC
amplifier (Model 1700, A-M Systems, USA) with signal low-pass filtered at 500 Hz. The signal was
digitized at 1 kHz sample rate by a 16-bit A/D converter (Minidigi 1-B, Molecular Devices, San Jose,
CA, USA) using the Axoscope 10 software (Molecular Devices, San Jose, CA, USA). Data were stored
in a PC for offline processing.
4.4. Action Potential (AP) Recording
Left ventricle preparations were used to assess the action potential profile. Muscle strips (≈0.5 cm)
were cut and pinned to the bottom of a tissue bath. The preparations were perfused with Tyrode’s
Solution containing (in mM): NaCl 140; KCl 5; MgCl2 1.8; 11 glucose; HEPES 5; CaCl2 2 (pH 7.4 adjusted
with NaOH at 37 ◦C) saturated with oxygen (100%) at a constant flow of 5 mL/min with a peristaltic
pump (Miniplus 3, Gilson, USA). The tissue was stimulated at four different basic cycle lengths (BCLs)
1000, 800, 500 and 300 ms using field stimulation. Transmembrane potential was recorded using glass
microelectrodes filled with 3 M KCl, connected to a high input impedance microelectrode amplifier
(Electro 705, WPI, USA). Amplified signals were digitized (1440 Digidata A/D interface, Molecular
Devices, San Jose, CA, USA) and stored in a computer for later analysis using the software LabChart
7 (AD Instruments, Bella Vista, New South Wales, Australia). Afterwards, the resting membrane
potential (RMP), action potential amplitude (APA), maximum speed of depolarization (dV/dt) and
action potential duration at 90% (APD90) and 30% (APD30) of the repolarization were analyzed.
The action potential triangulation was calculated by subtracting APD30 from APD90.
4.5. Cardiomyocytes Isolation
Following the treatment period, the animals were heparinized and euthanized. The hearts were
quickly excised by thoracotomy, weighed and cannulated by the aorta in a modified Langendorff
apparatus for retrograde perfusion with oxygenated Tyrode’s solution (in mM): NaCl 140; KCl 4;
MgCl2 1; HEPES 10; glucose 10; and CaCl2 2; pH adjusted to 7.4 with NaOH at 37 ◦C in a constant 10
mL/min flow rate. After 5 min, perfusion solution was changed to nominally Ca2+-free Tyrode’s solution.
After the hearts stopped beating, type II collagenase (Worthington Biochemical, NJ, USA) was added
to Ca2+-free Tyrode’s solution in a 0.5 mg/mL concentration and recirculated for 8 min. To complete
digestion, the hearts were washed with Ca2+-free Tyrode’s solution for 20 min. The epicardium of
the left ventricles was dissected, minced and gently shaken to dissociate cardiomyocytes. Isolated
cells were stored in modified KB solution (in mM): KCl 30; glutamic acid 70; KH2PO4 10; MgCl2 1;
taurine 20; HEPES 10; glucose 10; EGTA 0.3; pH = 7.3 with KOH at room temperature (23–25 ◦C).
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4.6. HEK293 Cell Culture and Transfection
Human Embryonic Kidney cells (HEK293) and HEK293 cell lines stably expressing hERG
channel (HEK-hERG) or Kv.4.3 channel (HEK-Kv4.3) were cultured in DMEM (Dubelcco’s
modified Eagle’s medium), supplemented with 10% of fetal bovine serum and 1% of
penicillin-streptomycin-amphotericin cocktail. HEK-hERG or HEK-Kv4.3 grew in the presence
of 50 µM of geneticin. Cell cultures were maintained in 5% CO2 at 37 ◦C. HEK293 cells were transfected
with plasmids containing genes related to human ion channel IKs. The transfections into HEK293 cells of
1 µg/mL, 0.5 µg/mL and 0.2 µg/mL of plasmid containing cDNA of KCNQ1, KCNE1 (2:1 ratio) and GFP,
respectively, was performed using Lipofectamine 2000 (Invitrogen) according to the instruction of
the manufacturer.
4.7. Patch–Clamp Recordings in Cardiomyocytes
Isolated myocytes were transferred to a shallow chamber and allowed to settle for at least 30 min
before being superfused with the external bathing solution (Tyrode’s solution with nicardipine 10 µM
for Ito or without nicardipine for ICa-L). Only Ca2+-tolerant rod-shaped cells, with clear cross-striations
and lacking any visible blebs on their surfaces were used. All experiments were performed at
room temperature (23–25 ◦C). Ionic currents were recorded using the whole-cell configuration of the
patch–clamp technique with an Axopatch-1D patch–clamp amplifier (Axon Instruments, Inc., USA).
Recording pipettes were obtained from borosilicate tubes (Sutter Instruments, Novato, CA, USA) and
had a tip resistance of 2–5 MΩ when filled with the internal solution (in mmol/L): CsCl 110; TEACl 30;
Mg-ATP 5; EGTA 10; HEPES 10 and Na-GTP 0.1 to record the L-type Ca2+ current, ICa-L or KCl 125;
NaCl 10; MgCl2 5; HEPES 10 and EGTA 5 to record the transient outward K+ current, Ito.
Following the patch rupture, whole cell membrane capacitances were measured from integration
of the capacitive transients elicited by voltage steps from −70 mV to −75, −65 and −60 mV, which did
not activate any voltage-dependent membrane current. For both Ito and ICa,L recording, voltage pulses
ranging from −50 to +60 mV, starting from a holding potential of −60 mV preceded by pre-pulse to
−40 mV were applied and current amplitudes were normalized to cell capacitance and expressed as
pA/pF. Steady-state activation curve of Ito or Ica-L was obtained from the I–V ratio, calculating the
conductance (G) to the K+ or Ca2+ ion, respectively.
To evaluate the voltage dependence of the Ito stationary inactivation (Steady-state inactivation),
a double-pulse protocol was used ranging from −90 to +30 mV, starting from a holding potential of
−80 mV followed by pulse to +60 mV. Recovery from inactivation of Ito was assessed by a double-pulse
protocol from −80 to +60 mV, where the time between two consecutive pulses was variable.
To evaluate the voltage dependence of the ICa-L steady-state inactivation, a double-pulse protocol
was used ranging from −90 to +40 mV, starting from a holding potential of −80 followed by a pulse
to 0 mV.
4.8. Patch–Clamp Recordings in HEK293 Cells
HEK293 cells plates were superfused with the external bathing solution containing (in mmol):
NaCl 136; KCl 4; CaCl2 1.8; MgCl2; HEPES-Na 10 and glucose 10 (pH 7.4) with or without
methylmercury chloride (CH3HgCl) that was used in 0.01 nM, 0.1 nM and 1 nM concentrations.
All experiments were performed at room temperature (21–22 ◦C). Ionic currents were recorded using
the whole-cell configuration of the patch–clamp technique with an Axopatch-200B patch–clamp
amplifier (Axon Instruments, Inc., USA). Recording pipettes were obtained from borosilicate tubes
(Sutter Instruments, USA) and had a tip resistance of 1–3 MΩ when filled with the internal solution
(in mmol/L): KCl 125; MgCl2 5; EGTA-K 5; HEPES-K 10; ATP-Na 5 (pH 7.2). Following the patch
rupture, whole cell membrane capacitances were measured from integration of the capacitive transients
elicited by voltage steps from −50 to −60 mV, which did not activate any voltage-dependent membrane
current. Currents amplitudes were normalized to cell capacitance and expressed as pA/pF.
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For HEK-hERG recording, voltage pulses ranging from −80 to +50 mV starting from a holding
potential of −90 mV followed by a post-pulse to −40 mV, were applied. Steady-state activation curve of
HEK-hERG was obtained from the I–V ratio of tail current. To evaluate the fully activated HEK-hERG
current, a double-pulse protocol was used ranging from −120 to +60 mV, preceded by a pulse to
+40 mV starting from a holding potential of −90 mV.
For KCNQ1/KCNE1 recording in transfected HEK293 cells, voltage pulses ranging from −40 to
+50 mV starting from a holding potential of −80 mV were applied. Steady-state activation curve of
KCNQ1/KCNE1 was obtained from the I–V ratio.
For HEK-Kv4.3 recording, voltage pulses ranging from −30 to +50 mV starting from a holding
potential of −80 mV were applied. Steady-state inactivation curve of HEK-KV4.3 a double-pulse
protocol was used ranging from −100 to +10 mV, starting from a holding potential of −80 mV followed
by a pulse to +50 mV. Inactivation recovery of Kv4.3 channels was assessed by a double-pulse protocol,
where the time between the two pulses from −80 to +50 mV was variable.
4.9. Computational Modeling
Human ventricular action potentials of 100 control individuals were simulated using the
O’Hara–Rudy dynamic (ORd) model as baseline [35]. Ionic conductances were varied between
20–200% of the O’Hara–Rudy “average human” to generate models with different ion current profiles
keeping the AP parameters within the normal range [36]. The simulations presented were conducted
using Virtual Assay, Copyright© 2016, University of Oxford (v.1.3.640 2014 Oxford University
Innovation, Ltd., Oxford, UK), a software package for in silico drug assays, kindly provided by
B. Rodríguez.
In order to reproduce the effects of MeHg in this population of 100 AP models, ionic conductances
were modified according to our experimental findings in human ion channels in human cells. Trains of
300 APs were evoked at 1 Hz and the last AP trace in each simulation was presented. The simulations
were carried out either in resting conditions or after β-adrenergic stimulation.
4.10. Statistical Analysis
Data are presented as mean ± SEM. Comparisons between groups were performed using Student’s
t-test or one-way analysis of variance, followed by a Bonferroni multiple comparison test. Values of
p < 0.05 were considered statistically significant. All analyses were performed using GraphPad Prism
5.0 (GraphPad Software, USA).
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/10/
3490/s1.
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